東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Development and Characterization of ...

Kim, Yujin .

Linked to FindBook

Google Book

Amazon

博客來

Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery./
Author:	Kim, Yujin .
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
Description:	155 p.
Notes:	Source: Dissertations Abstracts International, Volume: 81-06, Section: B.
Contained By:	Dissertations Abstracts International81-06B.
Subject:	Pharmaceutical sciences. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27542891
ISBN:	9781392364826

Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery.
Kim, Yujin .

Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 155 p.

Source: Dissertations Abstracts International, Volume: 81-06, Section: B.

Thesis (D.Phil.)--Mercer University, 2020.

This item must not be sold to any third party vendors.

Skin provides an attractive route for drug delivery, as transdermal delivery systems can ensure noninvasive and sustained delivery of medication across the skin into systemic circulation. Although the skin is a convenient site for drug administration, it only permits passive penetration of permeants with certain physicochemical properties. As a result, different strategies or devices have been developed to enhance the drug permeation into and across skin.The first aim of this study was to evaluate the efficacy of multiple dosing of trolamine salicylate (TS) as a topical analgesic on in vitro skin permeation. Also, the effect of sonophoresis on topical delivery of analgesic was evaluated. Results suggested that the multiple dosing (17.4 ± 4.1 μg/sq.cm) delivered a significantly higher amount of drug than the single dose (6.5 ± 0.6 μg/sq.cm). Also, the use of ultrasound enhances topical absorption of TS into and across skin. In the second aim, we focused on developing a new formulation to reduce the frequency of application of topical analgesics. A Poly lactic-co-glycolic acid (PLGA) based bio-adhesive polymeric solutions were prepared successfully and formed a thin film upon application in situ. A significantly higher amount of TS was delivered from a formulation containing 20% PLGA (45 ± 4 µg/sq.cm) as compared to PLGA-free counterpart (0.6 ± 0.2 µg/sq.cm).In the third aim, hyaluronic acid (HA) microneedles (MNs) were fabricated with and without magnesium ascorbyl phosphate (MAP) to facilitate the delivery of the active agent into and across the skin. The results showed that successful fabrication of HA MN, and the application of the current MN technology enhanced the delivery of MAP into skin (96.8±3.9 µg/sq.cm) compared to passive delivery (44.9±16.3 µg/sq.cm).In the fourth aim, the feasibility of transdermal delivery of heparin, a hydrophilic macromolecule, through laser-microporated skin was investigated. There was no passive permeation of heparin across the skin. However, permeation of heparin from the laser-treated group delivered 13.4 ± 0.62 µg/sq.cm after 24 h. Furthermore, heparin was not delivered to either the epidermis or dermis passively, whereas the laser-treatment group enabled delivery of heparin to the epidermis as well as the dermis.

ISBN: 9781392364826Subjects--Topical Terms:

3173021
Pharmaceutical sciences.
Subjects--Index Terms:

Laser-assisted Drug Delivery

Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery.
LDR:03534nmm a2200361 4500 001 2269303
005 20200908090438.5
008 220629s2020 ||||||||||||||||| ||eng d
020 $a 9781392364826
035 $a (MiAaPQ)AAI27542891
035 $a AAI27542891
040 $a MiAaPQ $c MiAaPQ
100 1 $a Kim, Yujin . $3 3546619
245 1 0 $a Development and Characterization of Polymeric Formulations and Microneedles for Dermal Drug Delivery.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 155 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-06, Section: B.
500 $a Advisor: Banga, Ajay K.
502 $a Thesis (D.Phil.)--Mercer University, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Skin provides an attractive route for drug delivery, as transdermal delivery systems can ensure noninvasive and sustained delivery of medication across the skin into systemic circulation. Although the skin is a convenient site for drug administration, it only permits passive penetration of permeants with certain physicochemical properties. As a result, different strategies or devices have been developed to enhance the drug permeation into and across skin.The first aim of this study was to evaluate the efficacy of multiple dosing of trolamine salicylate (TS) as a topical analgesic on in vitro skin permeation. Also, the effect of sonophoresis on topical delivery of analgesic was evaluated. Results suggested that the multiple dosing (17.4 ± 4.1 μg/sq.cm) delivered a significantly higher amount of drug than the single dose (6.5 ± 0.6 μg/sq.cm). Also, the use of ultrasound enhances topical absorption of TS into and across skin. In the second aim, we focused on developing a new formulation to reduce the frequency of application of topical analgesics. A Poly lactic-co-glycolic acid (PLGA) based bio-adhesive polymeric solutions were prepared successfully and formed a thin film upon application in situ. A significantly higher amount of TS was delivered from a formulation containing 20% PLGA (45 ± 4 µg/sq.cm) as compared to PLGA-free counterpart (0.6 ± 0.2 µg/sq.cm).In the third aim, hyaluronic acid (HA) microneedles (MNs) were fabricated with and without magnesium ascorbyl phosphate (MAP) to facilitate the delivery of the active agent into and across the skin. The results showed that successful fabrication of HA MN, and the application of the current MN technology enhanced the delivery of MAP into skin (96.8±3.9 µg/sq.cm) compared to passive delivery (44.9±16.3 µg/sq.cm).In the fourth aim, the feasibility of transdermal delivery of heparin, a hydrophilic macromolecule, through laser-microporated skin was investigated. There was no passive permeation of heparin across the skin. However, permeation of heparin from the laser-treated group delivered 13.4 ± 0.62 µg/sq.cm after 24 h. Furthermore, heparin was not delivered to either the epidermis or dermis passively, whereas the laser-treatment group enabled delivery of heparin to the epidermis as well as the dermis.
590 $a School code: 1160.
650 4 $a Pharmaceutical sciences. $3 3173021
653 $a Laser-assisted Drug Delivery
653 $a Microneedle
653 $a Polymeric Formulation
653 $a Sustained Release Drug Delivery System
653 $a Topical Formulation
653 $a Transdermal Drug Delivery System
690 $a 0572
710 2 $a Mercer University. $b College of Pharmacy. $3 3546620
773 0 $t Dissertations Abstracts International $g 81-06B.
790 $a 1160
791 $a D.Phil.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27542891